Query: Survey high-content phenotypic screening approaches and mechanistic biomarker panels for evaluating anti-steatotic, anti-inflammatory, and anti-fibrotic compounds in vitro, covering lipid droplet quantification methodologies, transcriptomic/proteomic profiling, multiplex cytokine assays, and collagen deposition measurements

High-content phenotypic screening platforms have evolved to capture multiple dimensions of liver disease biology by integrating assays that quantify steatosis, inflammation, and fibrosis using diverse cellular and molecular endpoints. For instance, lipid droplet quantification is commonly achieved through high-resolution imaging techniques that employ specific fluorescent dyes such as Nile Red or BODIPY. Confocal and automated whole‐mount imaging enable accurate per-cell quantification of lipid droplet number, area, and intensity in both 2D and 3D liver models. These methodologies not only capture relative changes in intracellular lipid accumulation in response to anti-steatotic compounds—for example, reductions in triglyceride buildup under pharmacological treatment—but also augment the dynamic range and statistical power of the assay systems (parafati2020pluripotentstemcellderived pages 1-3, strobel2021a3dprimary pages 7-9).

Simultaneously, transcriptomic and proteomic profiling add a vital mechanistic layer by characterizing the molecular underpinnings of compound effects. Advanced RNA-sequencing methods and platforms like TempO-Seq are used to generate comprehensive gene expression profiles across nearly the entire human transcriptome, facilitating differential expression analysis and gene set enrichment analyses (GSEA). These approaches help delineate pathways central to lipid metabolism, inflammatory signaling, and fibrogenesis. For instance, transcriptomic signatures reveal downregulation of key pro-inflammatory cytokines and fibrotic markers, as well as upregulation of genes associated with metabolic normalization, corroborating the phenotypic observations seen in lipid droplet assays (kostadinova2024digitalpathologywith pages 18-18, strobel2021a3dprimary pages 3-4). Proteomic assessments further complement transcriptomic data by evaluating the abundance and modifications of critical proteins such as matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), which together regulate extracellular matrix (ECM) remodeling.

Multiplex cytokine assays are integrated into these systems to provide dynamic assessments of the inflammatory environment within the liver models. Technologies such as Magnetic Luminex enable simultaneous quantification of several cytokines and chemokines—including IL-1β, IL-6, IL-8, TNF-α, and MCP-1—in cell culture supernatants. These assays help monitor shifts in inflammatory mediator profiles upon treatment with anti-inflammatory compounds and capture subtle differences in cytokine secretion that might result from single or combinatorial treatment effects. The multi-analyte approach not only confirms the presence of inflammation under disease-mimicking conditions but also verifies attenuation of these responses by candidate drugs (lefever2022aquantitativesystems pages 23-24, strobel2021a3dprimary pages 5-6).

Regarding collagen deposition measurements, anti-fibrotic efficacy is evaluated using a combination of histological staining, biochemical quantification, and digital pathology. Techniques such as Sirius Red staining, coupled with polarized light microscopy, are routinely employed to visualize and quantify collagen fibrils. In addition, assays that measure secreted procollagen peptides (type I and III) provide sensitive biochemical readouts of new collagen synthesis. The integration of advanced AI-enabled digital pathology platforms, such as FibroNest™, facilitates automated and objective quantification of collagen deposition at a single-fiber level, offering a high-throughput and reproducible measure of fibrosis resolution in 3D human liver microtissue models (kostadinova2024digitalpathologywith pages 8-9, strobel2021a3dprimary pages 12-13).

Complementing these approaches, additional multi-omics data integration, including that obtained from computational analyses, supports the construction of robust mechanistic biomarker panels to evaluate anti-steatotic, anti-inflammatory, and anti-fibrotic interventions. This integration of quantitative image analysis with molecular and secretory biomarkers provides a comprehensive assessment, making these platforms highly relevant for bridging preclinical testing with clinical endpoints (ζαρειφη2022συστημικήμοντελοποίησηmutiomics pages 149-164, parafati2020pluripotentstemcellderived pages 13-15).

References:
1. (kostadinova2024digitalpathologywith pages 8-9): Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, and Mathieu Petitjean. Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3d mash model. Scientific Reports, Mar 2024. URL: https://doi.org/10.1038/s41598-024-55438-2, doi:10.1038/s41598-024-55438-2. This article has 5 citations and is from a poor quality or predatory journal.

2. (lefever2022aquantitativesystems pages 23-24): Daniel E. Lefever, Mark T. Miedel, Fen Pei, Johanna K. DiStefano, Richard Debiasio, Tong Ying Shun, Manush Saydmohammed, Maria Chikina, Lawrence A. Vernetti, Alejandro Soto-Gutierrez, Satdarshan P. Monga, Ramon Bataller, Jaideep Behari, Vijay K. Yechoor, Ivet Bahar, Albert Gough, Andrew M. Stern, and D. Lansing Taylor. A quantitative systems pharmacology platform reveals nafld pathophysiological states and targeting strategies. Metabolites, 12:528, Jun 2022. URL: https://doi.org/10.3390/metabo12060528, doi:10.3390/metabo12060528. This article has 9 citations and is from a peer-reviewed journal.

3. (strobel2021a3dprimary pages 12-13): Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, and Eva Thoma. A 3d primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports, Jul 2021. URL: https://doi.org/10.21203/rs.3.rs-737717/v1, doi:10.21203/rs.3.rs-737717/v1. This article has 33 citations and is from a poor quality or predatory journal.

4. (strobel2021a3dprimary pages 7-9): Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, and Eva Thoma. A 3d primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports, Jul 2021. URL: https://doi.org/10.21203/rs.3.rs-737717/v1, doi:10.21203/rs.3.rs-737717/v1. This article has 33 citations and is from a poor quality or predatory journal.

5. (kostadinova2024digitalpathologywith pages 18-18): Radina Kostadinova, Simon Ströbel, Li Chen, Katia Fiaschetti‑Egli, Jana Gadient, Agnieszka Pawlowska, Louis Petitjean, Manuela Bieri, Eva Thoma, and Mathieu Petitjean. Digital pathology with artificial intelligence analysis provides insight to the efficacy of anti-fibrotic compounds in human 3d mash model. Scientific Reports, Mar 2024. URL: https://doi.org/10.1038/s41598-024-55438-2, doi:10.1038/s41598-024-55438-2. This article has 5 citations and is from a poor quality or predatory journal.

6. (parafati2020pluripotentstemcellderived pages 1-3): Maddalena Parafati, Sang Hyo Bae, R. Jason Kirby, Martina Fitzek, Preeti Iyer, Ola Engkvist, David M. Smith, and Siobhan Malany. Pluripotent stem cell-derived hepatocytes phenotypic screening reveals small molecules targeting the cdk2/4-c/ebpα/dgat2 pathway preventing er-stress induced lipid accumulation. International Journal of Molecular Sciences, 21:9557, Dec 2020. URL: https://doi.org/10.3390/ijms21249557, doi:10.3390/ijms21249557. This article has 12 citations and is from a peer-reviewed journal.

7. (parafati2020pluripotentstemcellderived pages 13-15): Maddalena Parafati, Sang Hyo Bae, R. Jason Kirby, Martina Fitzek, Preeti Iyer, Ola Engkvist, David M. Smith, and Siobhan Malany. Pluripotent stem cell-derived hepatocytes phenotypic screening reveals small molecules targeting the cdk2/4-c/ebpα/dgat2 pathway preventing er-stress induced lipid accumulation. International Journal of Molecular Sciences, 21:9557, Dec 2020. URL: https://doi.org/10.3390/ijms21249557, doi:10.3390/ijms21249557. This article has 12 citations and is from a peer-reviewed journal.

8. (strobel2021a3dprimary pages 3-4): Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, and Eva Thoma. A 3d primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports, Jul 2021. URL: https://doi.org/10.21203/rs.3.rs-737717/v1, doi:10.21203/rs.3.rs-737717/v1. This article has 33 citations and is from a poor quality or predatory journal.

9. (strobel2021a3dprimary pages 5-6): Simon Ströbel, Radina Kostadinova, Katia Fiaschetti-Egli, Jana Rupp, Manuela Bieri, Agnieszka Pawlowska, Donna Busler, Thomas Hofstetter, Katarzyna Sanchez, Sue Grepper, and Eva Thoma. A 3d primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates. Scientific Reports, Jul 2021. URL: https://doi.org/10.21203/rs.3.rs-737717/v1, doi:10.21203/rs.3.rs-737717/v1. This article has 33 citations and is from a poor quality or predatory journal.

10. (ζαρειφη2022συστημικήμοντελοποίησηmutiomics pages 149-164): ΔΣ Ζαρείφη. Συστημική μοντελοποίηση muti-omics δεδομένων για εύρεση μηχανισμών ανθρώπινων ασθενειών. Unknown journal, 2022.
